Targeting STAT3 to Modulate the Effectiveness of Cardioprotective Conditioning Strategies Against Myocardial Ischemia-Reperfusion Injury in Subjects With Diabetic Cardiomyopathy.
6 affiliations
- 1Institute of Trauma and Metabolism, Zhengzhou Central Hospital Affiliated With Zhengzhou University, Zhengzhou, China.
- 2Department of Anesthesiology, Shenzhen Maternity and Child Healthcare Hospital, Shenzhen, Guangdong, China.
- 3Department of Anesthesiology and Perioperative Medicine, Zhengzhou Central Hospital Affiliated With Zhengzhou University, Zhengzhou, China.
- 4Cell Research and Transformation Center, Zhengzhou Central Hospital Affiliated With Zhengzhou University, Zhengzhou, China.
- 5Department of Cardiology, Zhengzhou Central Hospital Affiliated With Zhengzhou University, Zhengzhou, China.
- 6State Key Laboratory of Pharmaceutical Biotechnology, Department of Medicine, The University of Hong Kong, Hong Kong, China.
Abstract
Myocardial ischemia-reperfusion injury (MIRI) is a major cause of cardiovascular morbidity and mortality. Reperfusion, although essential for myocardial restoration, can paradoxically exacerbate injury through oxidative stress, calcium overload, mitochondrial permeability transition pore opening and inflammatory infiltration. The vulnerability to MIRI is substantially amplified in subjects with diabetes mellitus, where chronic hyperglycemia, insulin resistance, and the resulting oxidative stress and low-grade inflammation impair endogenous cardioprotective mechanisms and worsen postinfarction outcomes. Ischemic conditioning strategies, including preconditioning and postconditioning, serve as powerful innate methods to mitigate MIRI by exposing the myocardium to brief, sublethal ischemic episodes that activate crucial prosurvival signalling pathways. Among these pathways, the survivor activating factor enhancement pathway, which is mediated predominantly by signal transducer and activator of transcription 3 (STAT3), and the reperfusion injury salvage kinase pathway, which involves AKT and ERK, are particularly important. However, in many models of diabetes, diabetes-induced STAT3 dysfunction may disrupt these protective pathways, often making conditioning stimuli less effective. The precise mechanisms underlying this impairment remain incompletely understood. Additionally, paradoxical changes in STAT3 expression have been reported, and key posttranslational modifications of STAT3 have not yet been investigated in the context of diabetic MIRI. This review provides a critical appraisal of the role, regulatory mechanisms and therapeutic potential of STAT3 in ischemic conditioning in patients with diabetes and discusses strategies aimed at restoring cardioprotection in this high-risk population.
Related
- Precision Oxygen Modulation in the Reperfusion Era: Conditioning and Therapeutic Strategies in Ischemic Stroke.
- Arsenic trioxide-induced cardiotoxicity: insights into the oxidative stress-inflammation positive feedback loop, translational biomarkers and targeted cardioprotective strategies— a narrative review
- Effects of pre-competition conditioning strategies on acute sport performance in high-level athletes: a systematic review and network meta-analysis
- Myocardial Ischemia-Reperfusion Injury: Molecular Mechanisms and Innovative Therapeutic Strategies
- NETs and the thrombo-immune microenvironment: immune heterogeneity in recanalization, reperfusion, hemorrhagic transformation, and antithrombotic strategies
BibTeX
@article{wang2026targeting,
title = {{Targeting STAT3 to Modulate the Effectiveness of Cardioprotective Conditioning Strategies Against Myocardial Ischemia-Reperfusion Injury in Subjects With Diabetic Cardiomyopathy.}},
author = {Chunyan Wang and Wangli Tian and Saman Saedi and Hengzhen Cui and Danyong Liu and Qinjun Chu and Dongwei Yang and Zhengyuan Xia},
journal = {Journal of cellular and molecular medicine},
year = {2026},
month = oct,
doi = {10.1111/jcmm.71418},
url = {https://europepmc.org/article/MED/42920234},
note = {CC BY},
}
RIS
TY - JOUR
TI - Targeting STAT3 to Modulate the Effectiveness of Cardioprotective Conditioning Strategies Against Myocardial Ischemia-Reperfusion Injury in Subjects With Diabetic Cardiomyopathy.
AU - Chunyan Wang
AU - Wangli Tian
AU - Saman Saedi
AU - Hengzhen Cui
AU - Danyong Liu
AU - Qinjun Chu
AU - Dongwei Yang
AU - Zhengyuan Xia
PY - 2026
DA - 2026/10/01
JO - Journal of cellular and molecular medicine
DO - 10.1111/jcmm.71418
UR - https://europepmc.org/article/MED/42920234
AB - Myocardial ischemia-reperfusion injury (MIRI) is a major cause of cardiovascular morbidity and mortality. Reperfusion, although essential for myocardial restoration, can paradoxically exacerbate injury through oxidative stress, calcium overload, mitochondrial permeability transition pore opening and inflammatory infiltration. The vulnerability to MIRI is substantially amplified in subjects with diabetes mellitus, where chronic hyperglycemia, insulin resistance, and the resulting oxidative stress and low-grade inflammation impair endogenous cardioprotective mechanisms and worsen postinfarction outcomes. Ischemic conditioning strategies, including preconditioning and postconditioning, serve as powerful innate methods to mitigate MIRI by exposing the myocardium to brief, sublethal ischemic episodes that activate crucial prosurvival signalling pathways. Among these pathways, the survivor activating factor enhancement pathway, which is mediated predominantly by signal transducer and activator of transcription 3 (STAT3), and the reperfusion injury salvage kinase pathway, which involves AKT and ERK, are particularly important. However, in many models of diabetes, diabetes-induced STAT3 dysfunction may disrupt these protective pathways, often making conditioning stimuli less effective. The precise mechanisms underlying this impairment remain incompletely understood. Additionally, paradoxical changes in STAT3 expression have been reported, and key posttranslational modifications of STAT3 have not yet been investigated in the context of diabetic MIRI. This review provides a critical appraisal of the role, regulatory mechanisms and therapeutic potential of STAT3 in ischemic conditioning in patients with diabetes and discusses strategies aimed at restoring cardioprotection in this high-risk population.
SN - 1582-1838
SN - 1582-4934
ER -